Evaluation of the expression profile of extrapyramidal symptoms due to antipsychotics by data mining of Japanese adverse drug event report (JADER) database

Yakugaku Zasshi

Volumn 137, Issue 1, 2017, Pages 111-120

  Kose, Eiji ^a   Uno, Kana ^a   Hayashi, Hiroyuki ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Atypical antipsychotics; Extrapyramidal symptom; Japanese Adverse Drug Event Report database; Reporting odds ratio; Typical antipsychotics

Indexed keywords

ARIPIPRAZOLE; BLONANSERIN; BROMPERIDOL; CHLORPROMAZINE; CLOSPIPRAMINE; CLOZAPINE; EMONAPRIDE; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; OXYPERTINE; PALIPERIDONE; PERICIAZINE; PEROSPIRONE; PERPHENAZINE; PIMOZIDE; PIPAMPERONE; QUETIAPINE; RISPERIDONE; SPIPERONE; SULPIRIDE; SULTOPRIDE; TIMIPERONE; ZOTEPINE; TIE RECEPTOR;

ARTICLE; DATA BASE; DATA MINING; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INCIDENCE; ODDS RATIO; ONSET AGE; BASAL GANGLIA DISEASES; CHEMICALLY INDUCED; DRUG SURVEILLANCE PROGRAM; JAPAN;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DATA MINING; DATABASES AS TOPIC; HUMANS; INCIDENCE; JAPAN; ODDS RATIO; RECEPTORS, TIE;

EID: 85008406176     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.16-00219     Document Type: Article

References (28)

1. Miyamoto S., Duncan G. E., Marx C. E., Lie-berman J. A., Mol. Psychiatry, 10, 79-104 (2005).
2. Gebhardt S., Hurtling F., Hanke M., Mittendorf M., Theisen F. M., Wolf-Ostermann K., Grant P., Martin M., Fleischhaker C., Schulz E., Remschmidt H., Eur. Child Adolesc. Psychiatry, 15, 371-382 (2006).
3. Caroff S. N., Mann S. C., Campbell E. C., Sullivan K. A., J. Clin. Psychiatry, 63,12-19 (2002).
4. Conner D. F., Fletcher K. E., Wood J. S., J. Clin. Psychiatry, 62, 967-974 (2001).
5. Glazer W. M., J. Clin. Psychiatry, 61, 16-21 (2000).
6. Kane J. M., J. Clin. Psychiatry, 65, 16-20 (2004).
7. Leucht S., Corves C., Arbter D., Engel R. R., Li C., DavisJ. M., Lancet, 373,31-41 (2009).
8. Peluso M. J., Lewis S. W., Barnes T. R., Jones P. B, Br. J. Psychiatry, 200, 387-392 (2012).
9. Miller D. D., Caroff S. N., Davis S. M., Rosenheck R. A., McEvoy J. P., Saltz B. L., Riggio S., Chakos M. H., Swartz M. S., Keefe R.S., Stroup T.S., Lieberman J.A., Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, Br. J. Psychiatry, 193, 279-288 (2008).
10. Correll C. U., J. Am. Acad. Child Adolesc. Psychiatry, 47, 9-20 (2008).
11. Fujita T., Jpn. J. Pharmacoepidemiol., 14,27-36 (2009).
12. Umetsu R., Nishibata Y., Abe J., Suzuki Y., Hara H., Nagasawa H., Kinosada Y., Nakamura M., Yakugaku Zasshi, 134, 299304 (2014).
13. Umetsu R., Abe J., Ueda N., Kato Y., Nakayama Y., Kinosada Y., Nakamura M., Yakugaku Zasshi, 135, 991-1000 (2015).
14. Kato Y., Umetsu R., Abe J., Ueda N., Nakayama Y., Kinosada Y., Nakamura M., J. Pharm. Health Care Sci., 1, 15 (2015).
15. Ishiguro C., Nakamura S., Matsui K., Jpn. J. Pharmacoepidemiol., 15, 23-30 (2010).
16. Rothman K. J., Lanes S., Sacks S. T., Pharmacoepidemiol. Drug Saf., 13, 519-523 (2004).
17. van Puijenbroek E. P., Bate A., Leufkens H. G., Lindquist M., Orre R., Egberts A. C., Pharmacoepidemiol. Drug Saf., 11, 3-10 (2002).
18. Sauzet O., Carvajal A., Escudero A., Molok-hia M., Cornelius V. R., Drug Saf., 36, 9951006 (2013).
19. Yamada M., Handa J., Jpn. J. Pharmacoepidemiol., 19, 23-30 (2014).
20. Ohtani H., Sawada Y., Xenobio. Metabol. and Dispos, 16, 27-37 (2001).
21. Divac N., Prostran M., Jakovcevski I., Cerovac N., Biomed Res. Int., 656-370 (2014).
22. Onrust S. V., McClellan K., CNS Drugs, 15, 329-337 (2001).
23. Deeks E. D., Keating G. M., CNS Drugs, 24, 65-84 (2010).
24. Hosomi K., Park B., Inose R., Fujimoto M., Takada M., Jpn. J. Drug Inform., 17, 125-132 (2015).
25. Werner F. M., Covenas R., Expert Opin. Drug Saf., 13, 1031-1042 (2014).
26. Matsui T., Umetsu R., Kato Y., Ueda N., Abe J., Nakayama Y., Hane Y., Kinosada Y., Nakamura M., Jpn. J. Drug Inform., 17, 145-154 (2015).
27. Trosch R. M., J. Am. Geriatr. Soc., 52, S266-S271 (2004).
28. Morikawa K., Bull. Natl. Inst. Health Sci., 129, 1-26 (2011).